Metabolic‐associated fatty liver disease is associated with severity of COVID‐19

Lignende værker

• Letter to the Editor: Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease
  af: Zheng, Kenneth I., et al.
  Udgivet: (2020)
• Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients
  af: Gao, Feng, et al.
  Udgivet: (2020)
• Association and Interaction Between Serum Interleukin-6 Levels and Metabolic Dysfunction-Associated Fatty Liver Disease in Patients With Severe Coronavirus Disease 2019
  af: Gao, Feng, et al.
  Udgivet: (2021)
• Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis
  af: Zhou, Yu-Jie, et al.
  Udgivet: (2020)
• Positive Association Between Ultrasonographic Fatty Liver Indicator and the Severity of Coronary Artery Disease
  af: Tingqiu Wang, et al.
  Udgivet: (2025-05-01)